Immunovant, Inc.
IMVT
$13.84
-$1.38-9.07%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 374.69M | 472.94M | 560.01M | 635.37M | 690.94M |
| Total Receivables | 2.22M | 1.88M | 2.42M | 5.50M | 1.03M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 35.63M | 32.56M | 26.63M | 24.90M | 18.81M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 412.54M | 507.37M | 589.05M | 665.77M | 710.78M |
|
|
|||||
| Total Current Assets | 412.54M | 507.37M | 589.05M | 665.77M | 710.78M |
| Net Property, Plant & Equipment | 774.00K | 716.00K | 631.00K | 595.00K | 670.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.62M | 7.62M | -- | -- | -- |
| Total Assets | 420.93M | 515.71M | 589.68M | 666.37M | 711.45M |
|
|
|||||
| Total Accounts Payable | 19.82M | 20.73M | 11.04M | 7.16M | 3.91M |
| Total Accrued Expenses | 48.48M | 45.88M | 33.91M | 41.30M | 27.89M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 23.00K | 47.00K | 69.00K | 138.00K | 306.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 15.00K | -- |
| Total Other Current Liabilities | -- | -- | -- | 15.00K | -- |
| Total Current Liabilities | 68.32M | 66.65M | 45.02M | 48.61M | 32.10M |
|
|
|||||
| Total Current Liabilities | 68.32M | 66.65M | 45.02M | 48.61M | 32.10M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 68.32M | 66.65M | 45.02M | 48.61M | 32.10M |
|
|
|||||
| Common Stock & APIC | 1.48B | 1.47B | 1.46B | 1.44B | 1.43B |
| Retained Earnings | -1.13B | -1.02B | -912.83M | -825.68M | -750.36M |
| Treasury Stock & Other | 2.48M | 1.91M | 1.82M | 1.91M | -600.00K |
| Total Common Equity | 352.62M | 449.05M | 544.66M | 617.76M | 679.34M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 352.62M | 449.05M | 544.66M | 617.76M | 679.34M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 352.62M | 449.05M | 544.66M | 617.76M | 679.34M |
|
|
|||||